Trade Summary

2 days ago, Rowland Thomas Andrew, serving as SVP, HEAD - ESTABLISHED BRANDS at Ani Pharmaceuticals Inc (ANIP), sold 459 shares at $79.21 per share, for a total transaction value of $36,357.00. Following this transaction, Rowland Thomas Andrew now holds 38,271 shares of ANIP.

This sale represents a 1.00% decrease in Rowland Thomas Andrew's stake in the company. This is considered a medium-conviction trade.

The trade was executed on Tuesday, May 12, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, May 13, 2026, 1 day after the trade was made.

Ani Pharmaceuticals Inc operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.